Enjoy exclusive interviews with industry leaders from a wide range of listed small—and mid-cap companies and stay updated with the latest market and industry trends.Hosted by Ashleigh Barry, Michael Switow, Michelle Martin, and Moneer Barazi, Global One Media invites top leaders and influencers from the crypto, small, and mid-cap space to join them for informative and in-depth discussions. With each episode, investors are provided with quality insights that are easy to digest and understand. Get the inside scoop on the latest global trends and insights from leaders in various industries. Enjoying our episodes? Follow our podcast and hit the notification bell so that you don’t miss any new episodes.Watch our Stock To Watch interviews on YouTube: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1
All content for Stocks To Watch is the property of Global One Media and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Enjoy exclusive interviews with industry leaders from a wide range of listed small—and mid-cap companies and stay updated with the latest market and industry trends.Hosted by Ashleigh Barry, Michael Switow, Michelle Martin, and Moneer Barazi, Global One Media invites top leaders and influencers from the crypto, small, and mid-cap space to join them for informative and in-depth discussions. With each episode, investors are provided with quality insights that are easy to digest and understand. Get the inside scoop on the latest global trends and insights from leaders in various industries. Enjoying our episodes? Follow our podcast and hit the notification bell so that you don’t miss any new episodes.Watch our Stock To Watch interviews on YouTube: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1
A breakthrough that could reshape cancer treatment.GT Biopharma (NASDAQ: GTBP) is advancing its next generation TriKE® platform, an innovative immunotherapy that activates the body’s own natural killer cells to identify and destroy cancer. In this interview, Executive Chairman & CEO Michael Breen discusses the company’s latest clinical progress and the potential of its lead drug candidate, GTB-3650.He also shares insights into the science behind TriKE®, the company’s pipeline for solid tumors and autoimmune diseases, and its mission to develop more humane cancer therapies that bring real hope to patients worldwide.Learn more about GT Biopharma: https://www.gtbiopharma.com/Watch the full YouTube interview here: https://youtu.be/jduKYNKHMIYAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia
Stocks To Watch
Enjoy exclusive interviews with industry leaders from a wide range of listed small—and mid-cap companies and stay updated with the latest market and industry trends.Hosted by Ashleigh Barry, Michael Switow, Michelle Martin, and Moneer Barazi, Global One Media invites top leaders and influencers from the crypto, small, and mid-cap space to join them for informative and in-depth discussions. With each episode, investors are provided with quality insights that are easy to digest and understand. Get the inside scoop on the latest global trends and insights from leaders in various industries. Enjoying our episodes? Follow our podcast and hit the notification bell so that you don’t miss any new episodes.Watch our Stock To Watch interviews on YouTube: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1
